Aspen Neuroscience Sets IPO Price at $15 per Share
Aspen Neuroscience has officially priced its initial public offering at $15.00 per share. The company intends to issue 9.375 million shares, which is expected to generate approximately $140.6 million in gross proceeds. The offering includes a provision for underwriters to exercise a 30-day option to purchase up to an additional 1.406 million shares at the initial IPO price, minus underwriting discounts. This capital infusion marks a significant milestone for the company as it prepares for public market trading.
Topics: Equity Financing Initial Public Offering
Read the full article at Seeking Alpha
Part of the story Bambusa Therapeutics Upsizes IPO with Pricing at $16 Per Share (4 articles)